The Safety and Tolerability of Atopaxar (E5555) in ... - summitMD.com
The Safety and Tolerability of Atopaxar (E5555) in ... - summitMD.com
The Safety and Tolerability of Atopaxar (E5555) in ... - summitMD.com
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
LANCELOT-ACS<br />
PDF-XChange Viewer<br />
w w w.docu-track.co m<br />
Click to buy NOW!<br />
Inclusion Criteria<br />
PDF-XChange Viewer<br />
w w w.docu-track.co m<br />
Click to buy NOW!<br />
• Male or female; aged 18-80 years<br />
• Present<strong>in</strong>g with features <strong>of</strong> unstable ang<strong>in</strong>a or non-<br />
ST-elevation MI<br />
• At least one <strong>of</strong> the follow<strong>in</strong>g:<br />
1. Tropon<strong>in</strong> T or I or CK-MB upper limit <strong>of</strong> normal<br />
2. ECG changes <strong>com</strong>patible with ischemia (i.e. ST depression<br />
at least 1 mm <strong>in</strong> 2 contiguous leads or T wave <strong>in</strong>version > 3<br />
mm or any dynamic ST shift or transient ST elevation)<br />
• R<strong>and</strong>omization <strong>and</strong> treatment ≤ 72 hours <strong>of</strong> the<br />
onset <strong>of</strong> symptoms
Change language